Society of Nuclear Medicine and Molecular Imaging (SNMMI)

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), formerly the Society of Nuclear Medicine, is a nonprofit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging (PET and SPECT). The bulk of nuclear imaging exams relate to oncology, about a third to cardiac imaging and the rest for a variety of protocols, including imaging inflammation and beta-amyloid plaques that cause Alzheimer's disease. 

Video of SNMMI President Cathy Cutler explaining advocacy efforts for nuclear imaging. #SNMMI

Policy reforms in Washington that will impact nuclear imaging

SNMMI President Cathy Cutler, PhD, explains some of the key policy initiatives the society is pursuing to help support the field of nuclear medicine. 

Video of SNMMI President Cathy Cutler explaining the efforts to get U.S. production started for Mo-99 for a domestic supply of nuclear imaging isotopes. #RSNA #SNMMI #RSNA24 #RSNA2024 #isotopeshortage

U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging

Society of Nuclear Medicine and Molecular Imaging President, Cathy Cutler, explains the long road to jump-starting a new U.S. domestic supply of imaging isotopes.

Imaging advocacy group warns of supply shortage that’s having ‘profound negative impact’ on patient care

Radiologists took to Twitter to voice their frustrations over the worsening situation, while the manufacturer issued an update Thursday.   

FAPI PET/CT shows promise as a better radiotracer for cancer than 18F-FDG. It also can be used for detection of infection and inflammation.

VIDEO: 6 key advances in molecular imaging technology for PET and SPECT

Munir Ghesani, MD, President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), system chief of nuclear medicine at Mount Sinai Health, explains recent advances in nuclear imaging technology.

Two examples of PSMA-PET scans showing numerous prostate cancer metastases spread throughout the body. Many of these smaller tumors would not have been dected on previous standard-of-care imaging. Photo on left courtesy of SNMMI, right University of Chicago. #PSMAPET

PSMA-PET is rapidly changing the standard of care for prostate cancer patients

Adoption of PSMA-PET has been swift because it can significantly improve prostate cancer detection and treatment. SNMMI President Munir Ghesani, MD, explains how.

Thumbnail

CMS coverage decision for Alzheimer's drug, related PET scans sparks concern in imaging community

In a statement released on April 14, MITA cautioned that the coverage decision will “severely limit patient access” to amyloid PET diagnostics and anti-amyloid monoclonal antibodies treatment.

brain money alzheimer dementia

Imaging industry advocate slams feds’ failure to address PET coverage gap in recent ruling

The Society for Nuclear Medicine & Molecular Imaging expressed "strong opposition" following CMS' decision, arguing there is no evidence to support limiting pay for such scans. 

Thumbnail

FDA approves new therapy, complementary imaging agent for treating metastatic prostate cancer

Provider advocates praised the decision, calling it “one of the greatest success stories in nuclear medicine history.”

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.